- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04384302
Efficacy of Visual Training in Beach Tennis
Efficacy of Visual Training in Beach Tennis - a Pilot Study
Study Overview
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Wrocław, Poland, 50-370
- Recruiting
- Department of Optics and Photonics
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- experienced beach tennis player
- participants able and willing to participate in the study (including telemedicine supervision during the training phase)
- known and using full spectacles correction or its equivalent in contact lens correction
Exclusion Criteria:
- inability to give an informed consent
- any disease that causes visual opacity that unable to perform visual training
- participant unable to conduct full visual training course of the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Visual training
Pre-specidied visual training methods that use: the Marsden ball, tables that uses green-red visual stimuli, physical reation in response to the visual stimuli that uses the flippers or the preselected distances. One set of exercises per week was prepared. Each visual training will last for 15 minutes and should be performed by the participant in their home (using the telemedicine devices to control the conduction of each exercise) 3 times a week. |
Pre-defined visual training protocol including the optometrical unit exercises
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Optomechanical reaction time
Time Frame: 8 weeks
|
The reaction time between the visual stimulus and the motor reaction
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Static visual acuity
Time Frame: 8 weeks
|
Best-corrected visual acuity in static conditions expressed in logMAR
|
8 weeks
|
Dynamic visual acuity
Time Frame: 8 weeks
|
Best-corrected visual acuity in dynamic conditions expressed in logMAR
|
8 weeks
|
Overall performance during sparing match
Time Frame: 8 weeks
|
Overall performance of the player during the supervised match [percentage of properly conducted series of moves specific to rocket sports]
|
8 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The pace of macular fixation
Time Frame: 8 weeks
|
Checking the pace of macular fixation in the predefined text of equal lenght of words.
|
8 weeks
|
Reading rate during the optokinetic task
Time Frame: 8 weeks
|
Checking the reading rate during the optokinetic task.
|
8 weeks
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- ST001.2020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Visual Performance
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedVisual PerformanceUnited States
-
Alcon ResearchCompletedVisual Performance | Dry Eye Symptoms
-
PepsiCo Global R&DCompletedSkill Performance | Soccer Performance | Coffeeberry EffectsUnited Kingdom
-
PepsiCo Global R&DCompletedSleep | Cognitive Performance | Balance | Physical PerformanceAustralia
-
Atılım UniversityNot yet recruitingCognitive Performance | Physical PerformanceTurkey
-
Stanford UniversityNational Eye Institute (NEI)Enrolling by invitationRepetitive Transcranial Magnetic Stimulation | Visual Attention | Visual Cortical PlasticityUnited States
-
Brigham and Women's HospitalRecruitingIncidental Findings | Visual Attention | Visual Search | Hybrid SearchUnited States
Clinical Trials on Visual training
-
HES-SO Valais-WallisUniversity of Applied Sciences of Western SwitzerlandUnknownHemispatial NeglectSwitzerland
-
National Cheng-Kung University HospitalNot yet recruitingDevelopmental Delay | Preterm Children
-
Rutgers, The State University of New JerseyNathan Kline Institute for Psychiatric Research; University of California,...Unknown
-
University of MilanCompleted
-
National Taiwan University HospitalNot yet recruitingConvergence InsufficiencyTaiwan
-
University of WaterlooKing Saud UniversityCompleted
-
University of SalfordUniversity of Nottingham; University of Birmingham; Stroke Research Network; University...Completed
-
State University of New York College of OptometryState University of New York College of OptometryRecruitingQuality of Life | Visual Impairment | Functional Visual Loss | Low Vision BlindnessUnited States
-
University of MinnesotaNational Institute of Mental Health (NIMH)RecruitingPsychotic Disorders | Schizophrenia | Schizophrenia Spectrum and Other Psychotic Disorders | Schizoaffective Disorder | Psychosis | Schizo Affective Disorder | Schizophreniform Disorders | Psychoses, Affective | Psychotic Mood Disorders | Psychosis Nos/OtherUnited States
-
University of Alabama at BirminghamUniversity of California, RiversideRecruitingMacular Degeneration | Central Visual ImpairmentUnited States